What is GLP-1 therapy and how does it help with weight loss?

GLP-1 receptor agonists like semaglutide and tirzepatide reduce appetite and slow gastric emptying to support medically supervised weight loss. They require a prescription and provider evaluation — they are not appropriate for everyone.

How much does the medical weight loss program cost?

Programs start at $149/month — all-inclusive with no hidden fees and free shipping. Cost details are discussed during the provider consultation.

Does Sarasota Trim Clinic have a physical office?

No. Sarasota Trim Clinic is a telehealth service. There is no public walk-in office. Consultations, prescriptions, and medication delivery all happen remotely.

Is a prescription guaranteed after signing up?

No. Prescription medication is only provided when a licensed provider determines it is medically appropriate based on your individual health evaluation.

GLP-1 Medication Safety: What You Need to Know

GLP-1 medications have a well-documented safety profile, but they carry real risks and are absolutely not for everyone. This page outlines the critical contraindications, precautions, and emergency symptoms you must discuss with a healthcare provider before considering treatment.

Discuss Safety with a Provider

Absolute Contraindications

Under no circumstances should you take GLP-1 medications if you fall into the following categories:

Medullary Thyroid Carcinoma

Do not use if you or any family members have a history of MTC.

Multiple Endocrine Neoplasia (MEN) 2

Do not use if you have MEN 2 syndrome.

Pregnancy and Breastfeeding

GLP-1s are not recommended. You must discontinue use well before attempting to become pregnant.

Known Hypersensitivity

A prior severe allergic reaction to semaglutide, tirzepatide, or any of their ingredients.

Precautions to Discuss With Your Provider

Honest medical history disclosure is critical. You must tell your provider if you have a history of:

Pancreatitis (inflammation of the pancreas)
Gallbladder disease or gallstones
Kidney issues or reduced kidney function
Diabetic retinopathy (vision problems related to diabetes)
Elevated resting heart rate or heart conditions

Drug Interactions

Because GLP-1 medications slow stomach emptying, they can affect how your body absorbs oral medications. You must disclose all medications, supplements, and vitamins you currently take to your provider to avoid dangerous interactions.

What "Not FDA-Approved" Means

While FDA-approved brands (like Wegovy and Zepbound) undergo rigorous safety evaluations, compounded medications do not. Compounded GLP-1s lack FDA review for safety, efficacy, and consistency. Providers prescribe them during shortages, but you must understand they are legally distinct from FDA-approved brands.

Emergency Symptoms

Seek emergency medical care or call 911 immediately if you experience:

Severe, persistent abdominal pain (with or without vomiting) that may radiate to your back.
Swelling of your face, lips, tongue, or throat, or severe difficulty breathing (anaphylaxis).
A lump or swelling in your neck, hoarseness, or trouble swallowing.
Yellowing of your skin or eyes (jaundice).
Sudden changes in your vision.

Not a Substitute for Evaluation

This page cannot substitute for a provider evaluation of your specific health situation. Your unique medical history determines your safety profile. Data presented is adapted from public FDA and NIH resources.

MEDICAL SOURCES & FURTHER READING

These sources address the topics identified below. They provide general education, not individualized medical advice, a clinic endorsement or a prediction of your results. Prescription treatment requires evaluation by a licensed provider; eligibility, medication and dosing depend on individual circumstances.

U.S. Food and Drug Administration
Wegovy prescribing information and Medication Guide (PDF)
Semaglutide indications, mechanism, contraindications, thyroid warning, pancreatitis, pregnancy and adverse reactions; this label does not apply to compounded products.
U.S. Food and Drug Administration
Zepbound prescribing information and Medication Guide (PDF)
Tirzepatide indications, dual GIP/GLP-1 mechanism, contraindications and adverse reactions; this label does not apply to compounded products.
U.S. Food and Drug Administration
FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
Lack of FDA approval for compounded drugs, dosing errors, quality concerns and limits on compounding.

RESEARCH & REFERENCES

Once-Weekly Semaglutide in Adults with Overweight or Obesity
John P. H. Wilding, Rachel L. Batterham, Salvatore Calanna, et al.; STEP 1 Study Group · New England Journal of Medicine · 2021
Research published in the New England Journal of Medicine reported greater mean weight reduction with semaglutide plus lifestyle intervention than with placebo in the studied population. This was not a study of Sarasota Trim Clinic or compounded medication, and individual results vary.
Tirzepatide Once Weekly for the Treatment of Obesity
Ania M. Jastreboff, Louis J. Aronne, Nadia N. Ahmad, et al.; SURMOUNT-1 Investigators · New England Journal of Medicine · 2022
Research published in the New England Journal of Medicine reported weight reduction across the tirzepatide groups during a 72-week trial with lifestyle intervention. Results depended on the trial regimen and population, do not establish compounded-product equivalence, and are not a clinic outcome or a guarantee.